With the recent release of the 2022 Quality Payment Program (QPP) proposed rule, Azara’s Matt Fusan and Erica Arias dissect the proposed changes and the impact those changes could have to healthcare providers.
- Will clinicians begin to see greater ROI and higher payment adjustments as MACRA statutory requirements are fulfilled?
- What will it take to avoid a penalty?
- What is CMS’s plan for the future of MIPS with the end of the 5-year transition period after the 2021 performance year?
- What is going on with the APM Performance Pathway for 2022 and beyond?
Matt Fusan, SVP Product, Azara Healthcare
Erica Arias, Director of Client Success, Azara Healthcare